Elanco Animal Health (ELAN) Tops Q4 EPS by 6c; Guides FY23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
February 21, 2023 6:30 AM ESTFourth Quarter 2022 Financial Results: Revenue of $988 million Reported Net Loss of $54 million, Adjusted Net Income of $95 million Adjusted EBITDA of $174 million or 17.6% of Revenue Reported EPS of $(0.11), Adjusted EPS of $0.19 Net leverage ratio of 5.4x Adjusted EBITDA Full Year 2022 Financial Results: Revenue of $4,418 million Reported Net Loss of $74 million, Adjusted Net Income of $548 million Adjusted EBITDA of $1,023 million or 23.2% of Revenue Reported... More
